0 0
Description: A phase II Study to evaluate the Efficacy and Safety of Anlotinib Hydrochloride Combined with Nivolumab in the Treatment of Advanced Gastric Adenocarcinoma as second-line or salvage Therapy
Data type: Metagenome
Sample scope: Multispecies
Submitter: 熊延狮; 华大集团
Literatures
- PMID: 39406730
Release date: 2024-09-06
Last updated: 2024-09-06
DOI: 10.26036/CNP0005890
Data size: 606.74GB
